Liver X Receptor Agonists

Details for Australian Patent Application No. 2002303553 (hide)

Owner THE UNIVERSITY OF CHICAGO

Inventors Song, Ching; Liao, Shutsung; Dai, Qing

Agent Shelston IP

Pub. Number AU-A-2002303553

PCT Number PCT/US02/13594

PCT Pub. Number WO2002/090375

Priority 60/288,643 03.05.01 US

Filing date 2 May 2002

Wipo publication date 18 November 2002

International Classifications

C07J 009/00 Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

A61K 031/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 60/288,643 03.05.01 US

1 May 2003 Application Open to Public Inspection

  Published as AU-A-2002303553

4 August 2005 Amendment Made

  The nature of the amendment is: Amend the invention title to read Liver X Receptor Agonists

30 August 2007 Amendment Made

  The nature of the amendment is: Add co-inventor Dai, Qing 2003

27 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002303554-Increased heat exchange in two or three phase medium

2002303552-METHODS AND COMPOSITIONS FOR PREVENTION OF ANGIOPROLIFERATION